Information for "India apos;s Glenmark To Study Potential COVID-19 Drug Combination"
Jump to navigation
Jump to search
View the protection log for this page.
Basic information
Display title | India apos;s Glenmark To Study Potential COVID-19 Drug Combination |
Default sort key | India apos;s Glenmark To Study Potential COVID-19 Drug Combination |
Page length (in bytes) | 664 |
Page ID | 35400 |
Page content language | en - English |
Page content model | wikitext |
Indexing by robots | Allowed |
Number of redirects to this page | 0 |
Page protection
Edit | Allow all users (infinite) |
Move | Allow all users (infinite) |
Edit history
Page creator | KamiBazley64801 (talk | contribs) |
Date of page creation | 22:04, 5 July 2020 |
Latest editor | KamiBazley64801 (talk | contribs) |
Date of latest edit | 22:04, 5 July 2020 |
Total number of edits | 1 |
Total number of distinct authors | 1 |
Recent number of edits (within past 90 days) | 0 |
Recent number of distinct authors | 0 |